Williams C, Gray R, Hills R, Shires M, Zhang L, Zhao Z
J Clin Oncol. 2024; 42(29):3430-3442.
PMID: 39083705
PMC: 11458110.
DOI: 10.1200/JCO.23.02030.
Mlecnik B, Torigoe T, Bindea G, Popivanova B, Xu M, Fujita T
Cancers (Basel). 2022; 14(18).
PMID: 36139506
PMC: 9497086.
DOI: 10.3390/cancers14184346.
Mlecnik B, Bifulco C, Bindea G, Marliot F, Lugli A, Lee J
J Clin Oncol. 2020; 38(31):3638-3651.
PMID: 32897827
PMC: 7605397.
DOI: 10.1200/JCO.19.03205.
Stacy N, Lynch J, Arendt M, Avens L, McNeill J, Cray C
PLoS One. 2018; 13(7):e0200355.
PMID: 29990325
PMC: 6039040.
DOI: 10.1371/journal.pone.0200355.
von Blomberg B, Glerum J, Croles J, Stam J, Drexhage H
Br J Cancer. 1980; 41(4):609-17.
PMID: 7387858
PMC: 2010289.
DOI: 10.1038/bjc.1980.104.
Inhibition of lymphocyte response by prostaglandin-producing suppressor cells in patients with melanoma.
Murray J, KOLLMORGEN G
J Clin Immunol. 1983; 3(3):268-76.
PMID: 6224806
DOI: 10.1007/BF00915351.
Quantitative dinitrochlorobenzene contact sensitization in a normal population.
Catalona W, Taylor P, Chretien P
Clin Exp Immunol. 1972; 12(3):325-33.
PMID: 4642908
PMC: 1553595.
Proceedings: The effect of immunosuppression on cancer.
Penn I, Starzl T
Proc Natl Cancer Conf. 1972; 7:425-36.
PMID: 4587653
PMC: 3079479.
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.
Wybran J, Fudenberg H
J Clin Invest. 1973; 52(5):1026-32.
PMID: 4540711
PMC: 302356.
DOI: 10.1172/JCI107267.
Serial studies of immunocompetence of patients undergoing chemotherapy for acute leukemia.
Hersh E, Gutterman J, Mavligit G, McCredie K, Burgess M, Matthews A
J Clin Invest. 1974; 54(2):401-8.
PMID: 4527189
PMC: 301567.
DOI: 10.1172/JCI107775.
Tumour response to chemotherapy in animals that have been treated with the same drugs prior to tumour implantation: a model for studying host effects on apparent drug resistance.
Luk C, Tannock I
Br J Cancer. 1988; 58(2):133-8.
PMID: 3166902
PMC: 2246770.
DOI: 10.1038/bjc.1988.179.
Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.
CURRIE G, McElwain T
Br J Cancer. 1975; 31(2):143-56.
PMID: 1164466
PMC: 2009407.
DOI: 10.1038/bjc.1975.19.
Value of lymphocyte reactivity induced by phytohemagglutinin in the treatment of malignant diseases.
Fujimoto S, Minami T, Itoh B, Ishigami H, Miyazaki M
Jpn J Surg. 1977; 7(1):35-43.
PMID: 857063
DOI: 10.1007/BF02469405.
Effect of intravenous hyperalimentation on established delayed hypersensitivity in the cancer patient.
Copeland E, Fadyen Jr B, Dudrick S
Ann Surg. 1976; 184(1):60-4.
PMID: 820290
PMC: 1344308.
DOI: 10.1097/00000658-197607000-00010.
Chemotherapy, a double agent in respect of immune functions.
MATHE G
Cancer Chemother Pharmacol. 1978; 1(2):65-8.
PMID: 750105
DOI: 10.1007/BF00254037.
Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.
Weber W, MISSMAHL H, Mazloumi B
Klin Wochenschr. 1978; 56(18):905-9.
PMID: 713420
DOI: 10.1007/BF01489216.
